News
StockStory.org on MSN3h
Why Viatris (VTRS) Stock Is Up TodayShares of medication company Viatris (NASDAQ:VTRS) jumped 3% in the morning session after it received approval from the U.S.
Viatris (NASDAQ:VTRS) announced on Monday that the U.S. FDA has approved its Iron Sucrose Injection, USP, as a generic ...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the U.S. Food and Drug Administration (FDA) has approved Iron Sucrose Injection, USP, an intravenous iron replacement product ...
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...
Investing.com -- Viatris Inc (NASDAQ: VTRS) stock rose 2.6% following the U.S. Food and Drug Administration’s approval of the company’s Iron Sucrose Injection, USP, the first generic version of ...
5h
InvestorsHub on MSNViatris Shares Climb Following FDA Clearance of First Generic Iron Sucrose InjectionViatris Inc (NASDAQ:VTRS) saw its stock increase by 2.6% after the U.S. Food and Drug Administration approved its Iron ...
Spain’s women’s national team is making a coaching change two weeks after reaching the final of the European Championship. Montse Tomé will not have her contract renewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results